Virtual CME Program
COVID-19 Web Series Part 9: Important Treatment Considerations and Controversies
In the ninth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss ongoing treatment considerations and controversies. They will review the potential role of steroids and vitamins in treating and preventing COVID-19, as well as the safety of commonly used medications including ibuprofen, ARBs, and ACE inhibitors in patients with or at risk for COVID-19.
Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 5/28/2020 and they are subject to change as new information is published.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 5/28/2020
Expiration Date: 5/28/2021
Topics
Learning Objectives
- Assess the potential role of vitamins and supplements in the prevention of COVID-19
- Evaluate the safety of ibuprofen among patients with acute COVID-19 infection
- Analyze the potential benefits of corticosteroids among patients with COVID-19
- Assess the safety of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) in patients at risk of COVID-19
- Develop key areas for inquiry into COVID-19
Faculty
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health
Portland, OR
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
Executive Director, UC Irvine Program in Medical Education for the Latino Community
UC Irvine School of Medicine
Irvine, CA
Learn More
Supporters and Partners
Supported by
Not Applicable
Education Partner
Not Applicable